427 related articles for article (PubMed ID: 21292778)
1. Consensus recommendations for standard investigative workup: report of the International Myeloma Workshop Consensus Panel 3.
Dimopoulos M; Kyle R; Fermand JP; Rajkumar SV; San Miguel J; Chanan-Khan A; Ludwig H; Joshua D; Mehta J; Gertz M; Avet-Loiseau H; Beksaç M; Anderson KC; Moreau P; Singhal S; Goldschmidt H; Boccadoro M; Kumar S; Giralt S; Munshi NC; Jagannath S;
Blood; 2011 May; 117(18):4701-5. PubMed ID: 21292778
[TBL] [Abstract][Full Text] [Related]
2. Laboratory testing requirements for diagnosis and follow-up of multiple myeloma and related plasma cell dyscrasias.
Willrich MA; Katzmann JA
Clin Chem Lab Med; 2016 Jun; 54(6):907-19. PubMed ID: 26509779
[TBL] [Abstract][Full Text] [Related]
3. A descriptive study of plasma cell dyscrasias in Egyptian population.
Kassem NM; El Zawam H; Kassem HA; El Nahas T; El Husseiny NM; El Azeeim HA
J Egypt Natl Canc Inst; 2014 Jun; 26(2):67-71. PubMed ID: 24841156
[TBL] [Abstract][Full Text] [Related]
4. Investigative tools for diagnosis and management.
Munshi NC
Hematology Am Soc Hematol Educ Program; 2008; ():298-305. PubMed ID: 19074100
[TBL] [Abstract][Full Text] [Related]
5. Heavy/light chain specific immunoglobulin ratios provides no additional information than serum proteins electrophoresis and immunofixation for the diagnosis and the follow-up of intact immunoglobulin multiple myeloma patients.
Beaumont-Epinette MP; Moreau C; Besnard S; Latute F; Collet N; Sebillot M; Grosbois B; Bendavid C; Guenet L; Decaux O
Pathol Biol (Paris); 2015 Sep; 63(4-5):215-21. PubMed ID: 26319969
[TBL] [Abstract][Full Text] [Related]
6. [Free light chains assay: Indications and methods].
Martellosio JP; Leleu X; Roblot P; Martin M; Puyade M
Rev Med Interne; 2019 May; 40(5):297-305. PubMed ID: 30862366
[TBL] [Abstract][Full Text] [Related]
7. Consensus recommendations for risk stratification in multiple myeloma: report of the International Myeloma Workshop Consensus Panel 2.
Munshi NC; Anderson KC; Bergsagel PL; Shaughnessy J; Palumbo A; Durie B; Fonseca R; Stewart AK; Harousseau JL; Dimopoulos M; Jagannath S; Hajek R; Sezer O; Kyle R; Sonneveld P; Cavo M; Rajkumar SV; San Miguel J; Crowley J; Avet-Loiseau H;
Blood; 2011 May; 117(18):4696-700. PubMed ID: 21292777
[TBL] [Abstract][Full Text] [Related]
8. Protein electrophoresis and serum free light chains in the diagnosis and monitoring of plasma cell disorders: laboratory testing and current controversies.
Tate JR; Graziani MS; Mollee P; Merlini G
Clin Chem Lab Med; 2016 Jun; 54(6):899-905. PubMed ID: 27107838
[No Abstract] [Full Text] [Related]
9. Immunoglobulin heavy light chain test quantifies clonal disease in patients with AL amyloidosis and normal serum free light chain ratio.
Prokaeva T; Spencer B; Sun F; O'Hara RM; Seldin DC; Connors LH; Sanchorawala V
Amyloid; 2016 Dec; 23(4):214-220. PubMed ID: 27677679
[TBL] [Abstract][Full Text] [Related]
10. Serum-free light-chain analysis in diagnosis and management of multiple myeloma and related conditions.
Milani P; Palladini G; Merlini G
Scand J Clin Lab Invest Suppl; 2016; 245():S113-8. PubMed ID: 27467897
[TBL] [Abstract][Full Text] [Related]
11. Serum free light chains in the diagnosis and monitoring of patients with plasma cell dyscrasias.
Mayo MM; Johns GS
Contrib Nephrol; 2007; 153():44-65. PubMed ID: 17075223
[TBL] [Abstract][Full Text] [Related]
12. [Monoclonal gammopathy--multiple myeloma].
Dietzfelbinger H
MMW Fortschr Med; 2005 Jun; 147(24):32-3, 35-6. PubMed ID: 16001531
[TBL] [Abstract][Full Text] [Related]
13. Chromosome 13 deletion and hypodiploidy on conventional cytogenetics are robust prognostic factors in Korean multiple myeloma patients: web-based multicenter registry study.
Oh S; Koo DH; Kwon MJ; Kim K; Suh C; Min CK; Yoon SS; Shin HJ; Jo DY; Kwak JY; Kim JS; Sohn SK; Joo YD; Eom HS; Kim SH; Kim YS; Kim C; Mun YC; Kim H; Lee DS; Lee JH;
Ann Hematol; 2014 Aug; 93(8):1353-61. PubMed ID: 24671365
[TBL] [Abstract][Full Text] [Related]
14. International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders.
Dispenzieri A; Kyle R; Merlini G; Miguel JS; Ludwig H; Hajek R; Palumbo A; Jagannath S; Blade J; Lonial S; Dimopoulos M; Comenzo R; Einsele H; Barlogie B; Anderson K; Gertz M; Harousseau JL; Attal M; Tosi P; Sonneveld P; Boccadoro M; Morgan G; Richardson P; Sezer O; Mateos MV; Cavo M; Joshua D; Turesson I; Chen W; Shimizu K; Powles R; Rajkumar SV; Durie BG;
Leukemia; 2009 Feb; 23(2):215-24. PubMed ID: 19020545
[TBL] [Abstract][Full Text] [Related]
15. Chromosomal aberrations are shared by malignant plasma cells and a small fraction of circulating CD19+ cells in patients with myeloma and monoclonal gammopathy of undetermined significance.
Zojer N; Schuster-Kolbe J; Assmann I; Ackermann J; Strasser K; Hübl W; Drach J; Ludwig H
Br J Haematol; 2002 Jun; 117(4):852-9. PubMed ID: 12060120
[TBL] [Abstract][Full Text] [Related]
16. Recommendations for the study of monoclonal gammopathies in the clinical laboratory. A consensus of the Spanish Society of Laboratory Medicine and the Spanish Society of Hematology and Hemotherapy. Part I: Update on laboratory tests for the study of monoclonal gammopathies.
Cárdenas MC; García-Sanz R; Puig N; Pérez-Surribas D; Flores-Montero J; Ortiz-Espejo M; de la Rubia J; Cruz-Iglesias E
Clin Chem Lab Med; 2023 Nov; 61(12):2115-2130. PubMed ID: 37477188
[TBL] [Abstract][Full Text] [Related]
17. [Evaluation of the new Hevylite™ IgA assay for the diagnosis and follow-up of monoclonal gammopathies].
Lakomy D; Lemaire-Ewing S; Denimal D; Bastie JN; Lafon I; Caillot D
Ann Biol Clin (Paris); 2013; 71(2):157-63. PubMed ID: 23587579
[TBL] [Abstract][Full Text] [Related]
18. [Monoclonal gammopathies--from MGUS to myeloma].
Hess U; Heijnen IA
Ther Umsch; 2004 Feb; 61(2):161-7. PubMed ID: 15018400
[TBL] [Abstract][Full Text] [Related]
19. Multiple Myeloma, Version 3.2017, NCCN Clinical Practice Guidelines in Oncology.
Kumar SK; Callander NS; Alsina M; Atanackovic D; Biermann JS; Chandler JC; Costello C; Faiman M; Fung HC; Gasparetto C; Godby K; Hofmeister C; Holmberg L; Holstein S; Huff CA; Kassim A; Liedtke M; Martin T; Omel J; Raje N; Reu FJ; Singhal S; Somlo G; Stockerl-Goldstein K; Treon SP; Weber D; Yahalom J; Shead DA; Kumar R
J Natl Compr Canc Netw; 2017 Feb; 15(2):230-269. PubMed ID: 28188192
[TBL] [Abstract][Full Text] [Related]
20. The Ig heavy chain gene is frequently involved in chromosomal translocations in multiple myeloma and plasma cell leukemia as detected by in situ hybridization.
Nishida K; Tamura A; Nakazawa N; Ueda Y; Abe T; Matsuda F; Kashima K; Taniwaki M
Blood; 1997 Jul; 90(2):526-34. PubMed ID: 9226151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]